Is BPC 157 Legal? Understanding Its Status and Implications FDA to weigh easing limits on unproven peptides favored by RFK Jr. and other MAHA figures Pittsburgh Post Gazette The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157: Miracle Healing Peptide or Hidden Danger? FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling